LUCD
Lucid Diagnostics Inc
NASDAQ: LUCD · HEALTHCARE · MEDICAL DEVICES
$1.07
+3.88% today
Updated 2026-04-30
Market cap
$199.66M
P/E ratio
—
P/S ratio
42.43x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Lucid Diagnostics Inc (LUCD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-113700.00 | $-2.36M | $-5.63M | $-17.67M | $-29.68M | $-32.82M | $-44.14M | $-46.48B |
| Capital expenditures | $862000.00 | $4.00 | $862000.00 | $862000.00 | $908000.00 | $221000.00 | $646000.00 | $197000.00 |
| Depreciation | $4000.00 | $4000.00 | $4000.00 | $4000.00 | $1.94M | $2.50M | $1.17M | — |
| Stock-based comp | $79850.00 | $173945.00 | $65000.00 | $9.60M | $14.99M | $6.82M | $4.53M | $4.39B |
| Free cash flow | $-975700.00 | $-2.36M | $-6.49M | $-18.53M | $-30.59M | $-33.04M | $-44.79M | $-46.49B |
| Investing cash flow | $-862000.00 | $-862000.00 | $-862000.00 | $-862000.00 | $-4.11M | $-221000.00 | $-646000.00 | — |
| Financing cash flow | $131500.00 | $2.50M | $5.58M | $72.08M | $2.61M | $29.46M | $48.25M | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-31.18M | — | — | — |